You are here: Industry Insights > Pfizer

News List

Pfizer receives CHMP positive opinion for novel COVID-19 oral treatment WorldPharmaNews
February 07, 2022
Pfizer Inc. (NYSE: PFE) announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the conditional marketing authorization...
EU drug regulator OKs Pfizer COVID pill for high-risk patients ExpressPharma
January 29, 2022
The endorsement by EMA for a conditional approval, if followed as usual by the European Commission, allows EU member states to deploy the drug after the regulator gave guidance for its emergency use late last year.
Pfizer obtains positive EMA CHMP opinion for oral Covid-19 treatment Pharmaceutical-Technology
January 29, 2022
The recommendation is based on scientific data including results from the Phase II/III EPIC-HR clinical trial of Paxlovid.
Pfizer and BioNTech initiate study to evaluate Omicron-based COVID-19 vaccine in adults 18 to 55 years of age WorldPharmaNews
January 28, 2022
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced the initiation of a clinical study to evaluate the safety, tolerability and immunogenicity of an Omicron-based vaccine candidate in healthy adults 18 through 55 years of age.
Omicron relief: Pfizer and BioNTech initiate study into targeted vaccine pharmatimes
January 26, 2022
COVID-19 vaccine luminaries Pfizer and BioNTech study will examine data from the current booster and consider need for specific Omicron jab。
Pfizer Begins Testing COVID-19 Vaccine Targeted to Omicron drugs.com
January 25, 2022
Pfizer Inc. announced Tuesday that it has launched a trial that will compare its existing COVID-19 vaccine against...
Moderna vax may lead to fewer breakthrough COVID infections than Pfizer ExpressPharma
January 24, 2022
A research, published in the Journal of the American Medical Association, found those who received the Moderna vaccine were less likely to be hospitalised, compared to recipients of the Pfizer-BioNTech vaccine.
Pfizer and OPKO Provide Update on the Biologics License Application for Somatrogon for Pediatric Growth Hormone Deficiency drugs.com
January 21, 2022
Pfizer Inc. (NYSE: PFE) and OPKO Health, Inc. (NASDAQ: OPK) announced today that the U.S. Food and Drug Administration (FDA) issued..
Fauci says FDA could authorize Pfizer's Covid vaccine for kids under 5 in the next month FirstWordPharma
January 20, 2022
White House chief medical advisor Anthony Fauci on Wednesday said the FDA could approve Pfizer and BioNTech's COVID-19 vaccine for children under 5-years-old in the next month, reported CNBC.
Pfizer shares in vitro efficacy of novel COVID-19 oral treatment against omicron variant WorldPharmaNews
January 19, 2022
Pfizer Inc. (NYSE: PFE) today shared results from multiple studies demonstrating that the in vitro efficacy of nirmatrelvir, the active main protease (Mpro) inhibitor of PAXLOVID™ (nirmatrelvir [PF-07321332] tablets and ritonavir tablets)...

Previous page 1 2 3 4 5 6 7 8 9 10 ... 83 84 Next page